The Potential Role of Human Induced Pluripotent Stem Cells (Hipsc) - Derived In Cardiomyocytes in Cardiovascular Disease – Review
Chennuru Veeranjaneyulu and
Gangapatnam Subrahmanayam
Additional contact information
Chennuru Veeranjaneyulu: Department of Advanced ResearchCenter, Narayana Medical Institutions, India
Gangapatnam Subrahmanayam: Director & Interventional Cardiologist, Narayana Medical Institutions, India
Current Trends in Biomedical Engineering & Biosciences, 2018, vol. 11, issue 3, 67-69
Abstract:
Cardiovascular disease (CVD) is a disturbing health problem accounts for a huge proportion of mortality worldwide. Existing treatment is restricted and research is ongoing to discuss this severe health problem. As mortality rates rise, the demand for innovative therapeutics has pressed the pharmaceutical engineering to discover unconventional methodologies for CVD drug development. The beginning of human induced pluripotent stem cell (hiPSC) technology has rejuvenated the efforts in the previous decade to recognize more completely the prospective of human embryonic stem cells for scientific research.
Keywords: juniper publishers group; juniper publishers Biomedical Engineering journals; Biomedical Engineering journals list; medical devices journals; peer reviewed Biomedical Engineering journals; open access Biomedical Engineering journals; Biomedical Engineering journals impact factor; Biomedical Engineering scientific journals; Biomedical Engineering articles; scholarly Biomedical Engineering journals; juniper publishers reivew (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations:
Downloads: (external link)
https://juniperpublishers.com/ctbeb/pdf/CTBEB.MS.ID.555814.pdf (application/pdf)
https://juniperpublishers.com/ctbeb/CTBEB.MS.ID.555814.php (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:adp:jctbeb:v:11:y:2018:i:3:p:67-69
DOI: 10.19080/CTBEB.2018.11.555814
Access Statistics for this article
Current Trends in Biomedical Engineering & Biosciences is currently edited by Sophia Mathis
More articles in Current Trends in Biomedical Engineering & Biosciences from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().